Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
GS-4528 by Gilead Sciences for Melanoma: Likelihood of Approval
GS-4528 is under clinical development by Gilead Sciences and currently in Phase I for Melanoma. According to GlobalData, Phase I...
Data Insights
GS-4528 by Gilead Sciences for Metastatic Renal Cell Carcinoma: Likelihood of Approval
GS-4528 is under clinical development by Gilead Sciences and currently in Phase I for Metastatic Renal Cell Carcinoma. According to...